PX91:F Cassava Sciences Inc

EUR 21.41 0.00 0
Icon

Cassava Sciences Inc (PX91:F) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | F
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

EUR 21.41

0.00 (0.00)%

EUR 0.85B

25.00

N/A

N/A

Icon

PX91:F

Cassava Sciences Inc (EUR)
COMMON STOCK | F
EUR 21.41
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

EUR 0.85B

N/A

EUR 21.41

Cassava Sciences Inc (PX91:F) Stock Forecast

N/A

Based on the Cassava Sciences Inc stock forecast from 0 analysts, the average analyst target price for Cassava Sciences Inc is not available over the next 12 months. Cassava Sciences Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Cassava Sciences Inc is Bearish, which is based on 2 positive signals and 5 negative signals. At the last closing, Cassava Sciences Inc’s stock price was EUR 21.41. Cassava Sciences Inc’s stock price has changed by +3.48% over the past week, -2.10% over the past month and -12.99% over the last year.

No recent analyst target price found for Cassava Sciences Inc
No recent average analyst rating found for Cassava Sciences Inc

Company Overview Cassava Sciences Inc

Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate ...Read More

6801 N. Capital of Texas Hwy, Bldg 1, Austin, TX, United States, 78731

26

December

EUR

Germany

Adjusted Closing Price for Cassava Sciences Inc (PX91:F)

Loading...

Unadjusted Closing Price for Cassava Sciences Inc (PX91:F)

Loading...

Share Trading Volume for Cassava Sciences Inc Shares

Loading...

Compare Performance of Cassava Sciences Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for PX91:F

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Cassava Sciences Inc (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
NOVA:F
Novo Nordisk A/S 0.00 (0.00%) EUR506.56B 45.40 4.43

ETFs Containing PX91

Symbol Name PX91's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Cassava Sciences Inc (PX91:F) Stock

Stock Target Advisor's fundamental analysis for Cassava Sciences Inc's stock is Bearish.

Unfortunately we do not have enough data on PX91:F's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on PX91:F's stock to indicate what its average analyst target is.

Unfortunately we do not have enough data on PX91:F's stock to indicate if its overvalued.

The last closing price of PX91:F's stock was EUR 21.41.

The most recent market capitalization for PX91:F is EUR 0.85B.

Unfortunately we do not have enough analyst data on PX91:F's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Cassava Sciences Inc's stock.

As per our most recent records Cassava Sciences Inc has 26 Employees.

Cassava Sciences Inc's registered address is 6801 N. Capital of Texas Hwy, Bldg 1, Austin, TX, United States, 78731. You can get more information about it from Cassava Sciences Inc's website at https://www.cassavasciences.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...